MedPath

Cognitive Behavioral Therapy for Insomnia in Euthymic Bipolar Disorder

Not Applicable
Completed
Conditions
Insomnia
Bipolar Disorder
Interventions
Behavioral: Cognitive behavioral therapy for insomnia
Registration Number
NCT01704352
Lead Sponsor
Norwegian University of Science and Technology
Brief Summary

Patients with bipolar disorder suffer from sleep disturbances, even in euthymic phases. Changes in sleep are frequent signs of a new episode of (hypo)mania or depression. Cognitive behavioral therapy for insomnia is an effective treatment for primary insomnia, but has not been introduced to patients with bipolar disorder. The aim is to compare cognitive behavioral therapy added to 'treatment as usual' with just 'treatment as usual'. The investigators hypothesize that cognitive behavioral therapy will improve quality of sleep, stabilize minor mood variations and prevent new mood episodes in euthymic patients with bipolar disorder and insomnia.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
38
Inclusion Criteria
  • Fulfilling criteria for SCID-1-verified bipolar I or II disorder
  • Euthymic, as defined by Montgomery Åsberg Depression Rating Scale (MADRS) not higher than eleven, and Young Mania Rating scale (YMRS) not higher than five.
  • Fulfilling DSM-IV criteria for primary insomnia or insomnia related to another mental disorder, as assessed by the Insomnia Interview Schedule (IIS).
Exclusion Criteria
  • Being or having been in a defined affective episode the last month before inclusion
  • Hospitalization in the last two months before inclusion
  • Working night shifts
  • Sleep apnea
  • Medical conditions incompatible with participation.
  • Inability to cooperate in the 3-week initial phase before randomization.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
CBT-ICognitive behavioral therapy for insomniaCognitive behavioral therapy for insomnia (CBT-I) is a multicomponent treatment consisting of sleep restriction therapy, psychoeducation about sleep, stimulus control, stabilizing circadian rhythm and challenging beliefs and perception of sleep.
Primary Outcome Measures
NameTimeMethod
Change from baseline in quality of sleep at 8 weeksAt 8 weeks from randomization

As assessed by the Insomnia Severity Index (ISI)

Change from baseline in quality of sleep at 6 months follow-up6 months from end of treatment phase

As assessed by the Insomnia Severity Index (ISI)

Secondary Outcome Measures
NameTimeMethod
Variation in sleep registration from baseline to 6 months follow-upAt 6 months

Comparing registrations of sleep by sleep diaries, actigraphs and polysomnography.

Variation in sleep registration from baseline to 8 weeksAt 8 weeks

Comparing registrations of sleep by sleep diaries, actigraphs and polysomnography.

Trial Locations

Locations (1)

Østmarka Psychiatric Department, St Olavs Hospital

🇳🇴

Trondheim, Norway

© Copyright 2025. All Rights Reserved by MedPath